Worth reading
36Immaterial
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
379900
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise of Series 1 Stock Acquisition Rights with exercise price adjustment provisions issued through a third-party allotment
発行・処分する株式数379,900Shares
379,900 new shares
Intended allottee
Apricus Partners合同会社 (allottee of the previously issued stock acquisition rights)
発行済株式総数
2.8% (exercise ratio subject to exercise restrictions)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥988 (1 September), ¥955 (other exercise dates); details and floor of the adjustment provisions: Not disclosed
Number of Stock Acquisition Rights
Total issued: 35,000 rights; exercised during the month: 3,799 rights; unexercised at month-end: 12,940 rights
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
16 March 2026: Series 1 Stock Acquisition Rights with exercise price adjustment provisions issued through a third-party allotment (detailed amount: Not disclosed)
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise of Series 1 Stock Acquisition Rights with exercise price adjustment provisions issued through a third-party allotment |
| Number of shares to be issued or disposed of | 379,900 new shares |
| Intended allottee | Apricus Partners合同会社 (allottee of the previously issued stock acquisition rights) |
| Dilution Rate | 2.8% (exercise ratio subject to exercise restrictions) |
| Total number of issued shares | 18,925,929 shares (as of the end of the month preceding the month covered) → Not disclosed |
| Exercise price | ¥988 (1 September), ¥955 (other exercise dates); details and floor of the adjustment provisions: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 35,000 rights; exercised during the month: 3,799 rights; unexercised at month-end: 12,940 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | 16 March 2026: Series 1 Stock Acquisition Rights with exercise price adjustment provisions issued through a third-party allotment (detailed amount: Not disclosed) |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of these Stock Acquisition Rights in September 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.